Heather Valerio, Alison D Marshall, Anna Conway, Carla Treloar, Lisa Carter, Marianne Martinello, Charles Henderson, Janaki Amin, Phillip Read, David Silk, Louisa Degenhardt, Bianca Prain, Maryam Alavi, Gregory J Dore, Jason Grebely
BACKGROUND: Evaluating gender-specific trends in hepatitis C virus (HCV) treatment uptake among men and women who inject drugs is crucial for ensuring equitable progress towards HCV elimination. This study aimed to quantify differences in testing, treatment, and current HCV infection between men and women who inject drugs. METHOD: ETHOS Engage is an observational cohort study of people who inject drugs attending drug treatment clinics and needle and syringe programs in Australia recruited from May 2018-September 2019 (wave 1) and November 2019-April 2021 (wave 2)...
April 11, 2024: International Journal on Drug Policy